"We are UCI Health: A devoted team of nationally regarded physicians and nurses, researchers and clinicians, educators and students united by a single calling to improve the lives of the people in our community and beyond. As the only academic health system in Orange County, our multifaceted organization is dedicated to the discovery of new medical frontiers, to the teaching of future healers and to the delivery of the finest evidence-based care. We are unique in our ability to provide the most compassionate healthcare because were driven by our passion for innovation, grounded in the best medical and scientific knowledge."

During the past decade, UC Irvine Health Cancer Center-Newport conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 2 clinical trials were completed, i.e. on average, 8.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 2 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UC Irvine Health Cancer Center-Newport" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "SWOG Cancer Research Network" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "NRG Oncology" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UC Irvine Health Cancer Center-Newport" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "UC Irvine Health Cancer Center-Newport" are "Invasive Breast Carcinoma" (5 trials), "Chronic Lymphocytic Leukemia" (3 trials), "Colon Adenocarcinoma" (3 trials), "Small Lymphocytic Lymphoma" (3 trials) and "Advanced Malignant Solid Neoplasm" (2 trials). Many other conditions were trialed in "UC Irvine Health Cancer Center-Newport" in a lesser frequency.

Most popular intervention types in "UC Irvine Health Cancer Center-Newport" are "Other" (23 trials), "Drug" (20 trials), "Biological" (13 trials), "Procedure" (11 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (12 trials), "Questionnaire Administration" (8 trials), "Biospecimen Collection" (7 trials), "Laboratory Biomarker Analysis" (7 trials) and "Computed Tomography" (6 trials). Other intervention names were less common.

The vast majority of trials in "UC Irvine Health Cancer Center-Newport" are 27 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "UC Irvine Health Cancer Center-Newport". undefined are not yet recruiting, 9 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UC Irvine Health Cancer Center-Newport, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UC Irvine Health Cancer Center-Newport, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".